Risk Factors Update Summary
- Sales of products from top ten customers decreased from 26% to 20% of revenue.
- Debt decreased from $2.5 billion to $1.1 billion, with total debt to equity ratio dropping from 264% to 227%.
- Dependence on 1,000 suppliers for products in the U.S. segment, with 10 largest suppliers contributing 10% of revenue.
- Increased risk of cyberattacks due to advanced tools like artificial intelligence.
- Uncertainty in economic conditions may impact demand for products and services, affecting financial performance.
- Reliance on few vendors for Patient Direct segment may impact operations and cash flows.
- Litigation risks include intellectual property claims and product liability losses.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=75252&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.